Welcome to Regulatory Reconnaissance, your regulatory news and intelligence briefing. In Focus: US. 3 key issues to watch at FDA as Makary struggles …
Recon: FDA approves Cytokinetics’ heart drug in first for drugmaker – RAPS
Share This Story, Choose Your Platform!
About the Author: AJDesign77
